2025
Stereotactic radiosurgery as neuromodulation of refractory angina: an initial case series
CVEK, Jakub; Otakar JIRAVSKÝ; Lukas KNYBEL; Miroslav HUDEC; Radim SPACEK et al.Základní údaje
Originální název
Stereotactic radiosurgery as neuromodulation of refractory angina: an initial case series
Autoři
CVEK, Jakub; Otakar JIRAVSKÝ; Lukas KNYBEL; Miroslav HUDEC; Radim SPACEK; Adrian REICHENBACH; Jan HECKO; Radek NEUWIRTH a Josef KAUTZNER
Vydání
Radiation Oncology, LONDON, BMC, 2025, 1748-717X
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.200 v roce 2024
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/25:00140926
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Radiosurgery; Refractory angina
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 2. 4. 2025 12:36, Mgr. Tereza Miškechová
Anotace
V originále
BackgroundThis intervention pilot case series assessed 40-Gy stereotactic radiosurgery (SRS) neuromodulation applied to the bilateral stellate ganglion (SG) as a bailout procedure for patients with refractory angina pectoris (RAP).Materials and methodsThe local institutional review board approved this feasibility study. In three patients with RAP, after repeated good response, symptoms were temporarily relieved after anaesthetic blockade of the left SG under ultrasound guidance. Radiosurgical neuromodulation with a dose of 40 Gy in one fraction was used for more permanent pain control. When RAP recurred after the initial SRS, right-sided procedures were considered after a confirmed positive response to right SG anesthetic block.ResultsNo acute or late radiation-related toxicities were observed. Two patients (67%) responded to bilateral SRS (follow-up: 60 and 48 months, respectively). From baseline to 24 months, their average prescribed nitrate package count decreased from 5.5 to 0 and remained low. Daily emergency nitrates declined from 20 to 30 to 1-2 applications, and walking distance improved from 10 to 20 m to 200-400 m and remained stable. Quality of life as measured with the EQ-5D and all domains of the Seattle Angina Questionnaire improved. The third patient received only unilateral SRS, had a temporary improvement for 6 months before a return to baseline, and died after 42 months of follow-up.ConclusionsBilateral radiosurgical neuromodulation at 40 Gy appears to be feasible, safe, and effective as a bailout procedure for RAP.